What is the role of upfront pembrolizumab in metastatic PD-L1 positive NSCLC presenting with SVC syndrome?
10
1 AnswersMednet Member
Medical Oncology · Albert Einstein College of Medicine at Montefiore Medical Center
This is a "trick question" as there are at least 3 difficult questions hidden here-
- Can systemic therapy replace the need for local therapy in urgent clinical situations traditionally calling for radiation?
- What is the best upfront treatment regimen for a patient with PD-L1 positive NSCLC?
- What is t...